Skip to main content
. Author manuscript; available in PMC: 2009 Jan 14.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2008 May 22;28(8):1527–1533. doi: 10.1161/ATVBAHA.108.166975

Figure 2.

Figure 2

TER across HCMECs. A, LY333531 prevents PDBu-induced changes in barrier function during PKCβII overexpression (n=6, **P<0.05 vs vehicle). B, RFP-PKCβII translocation indicated by inverse changes in membrane versus cytosol FI. C, RFP-PKCβII distribution before and after activation. D, Rottlerin pretreatment enhances PDBu-induced TER decrease (n=4, ***P<0.001 vs vehicle).